Picture of Alkermes logo

ALKS Alkermes Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Annual cashflow statement for Alkermes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-48.2-158356367242
Depreciation
Deferred Taxes
Non-Cash Items91.7122107101104
Unusual Items
Other Non-Cash Items
Changes in Working Capital-25.512.7-36.7-98.2119
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities10221401439521
Capital Expenditures-28-38.3-48-33.5-40.4
Purchase of Fixed Assets
Other Investing Cash Flow Items-38.2-26.3101-77.8336
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-66.2-64.553.4-111295
Financing Cash Flow Items-16.6-18.2-303-29.6-31
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities29.1-1.57-290-49412.4
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash64.6-45.1165-166829